Published online Aug 15, 2024. doi: 10.4251/wjgo.v16.i8.3738
Revised: June 25, 2024
Accepted: July 8, 2024
Published online: August 15, 2024
Processing time: 80 Days and 22.6 Hours
A study on clinical outcomes and prognostic factors in T4N0M0 colon cancer patients after R0 resection revealed that ileostomy, T stage, right hemicolectomy, irregular follow-up, and CA199 level were independent risk factors affecting overall survival. T4-stage cancer invades the entire thickness of the intestinal tract, increasing the difficulty of treatment and the risk of recurrence, and requires a combination of chemotherapy, immunotherapy, and targeted therapy to control the spread of cancer cells. The prognosis of right hemicolectomy is significantly worse than that of left hemicolectomy, and right hemicolectomy is an inde
Core Tip: The incidence and mortality rates of colon cancer are increasing; while most cases involve advanced-stage disease, T4-stage disease is rare and poorly studied. Survival time is an important indicator of treatment effectiveness, and this study identified multiple independent risk factors. T4-stage cancer invades the entire thickness of the intestinal tract, increasing the difficulty of treatment and the risk of recurrence, and requires a combination of multiple treatment methods. The prognosis of right hemicolectomy is worse than that of left hemicolectomy, and right hemicolectomy is an independent risk factor for a poor prognosis. Advanced age, histopathological type, and lymph node metastasis are also risk factors.
- Citation: Wu CY, Ye K. Risk factors for the prognosis of colon cancer. World J Gastrointest Oncol 2024; 16(8): 3738-3740
- URL: https://www.wjgnet.com/1948-5204/full/v16/i8/3738.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i8.3738
We had the privilege of reading a study on the prognosis analysis of colorectal cancer conducted by Liu et al[1]. This retrospective analysis explored clinical outcomes and prognostic factors in T4N0M0 (i.e., stage III without lymph node metastasis) colorectal cancer patients who underwent R0 resection. The incidence and mortality rate of colorectal cancer have risen rapidly in recent years, and clinically, most colorectal cancer patients are in the middle or late stages, and some patients even present with obstruction of the digestive tract. A small percentage of colorectal cancer patients develop invasion of the peritoneal layer or adjacent organs or structures (T4-stage disease)[2,3] and are prone to lymph node metastasis. The occurrence of lymph node metastasis in T4-stage colorectal cancer patients after surgery is low, and studies on such patients are relatively rare. The authors collected data from 200 patients with pTNM stage T4N0M0 colorectal cancer and statistically analysed the data to construct a prognostic model. The prognostic model showed good consistency and accuracy in internal and external validation. The survival rate is an important indicator for evaluating the effectiveness of colorectal cancer treatment, and extending the survival time and improving the prognosis are important clinical issues for colorectal cancer patients. Analysis of the 3-year survival rate of colorectal cancer patients revealed that ileostomy, T stage, right hemicolectomy, irregular follow-up, and CA199 level were independent risk factors affecting the overall survival of T4N0M0 colorectal cancer patients.
T4-stage colorectal cancer patients have tumours that invade the entire thickness of the intestinal wall, which increases the difficulty of treatment to some extent and may cause cancer cells to shed and disperse, leading to posttreatment recurrence and increasing the risk of poor prognosis[4]. Therefore, for such colorectal cancer patients, clinicians can combine chemotherapy, immunotherapy, and targeted therapy to control the spread of tumour cells. In addition, surgeons should adhere strictly to the principle of not touching nontumor regions during surgery to prevent iatrogenic tumour dissemination.
The prognosis of stage IV colorectal cancer after right hemicolectomy is significantly worse than that after left hemicolectomy, and right hemicolectomy is an independent risk factor for poor prognosis, which has been supported by data from multiple different research institutions[5]. Similarly, Benedix et al[6] reported that the 5-year DFS rates of patients who underwent right hemicolectomy and those who underwent left hemicolectomy were 73% and 74%, respectively. However, some studies have shown that the 3-year disease-free survival rate and 3-year overall survival rate of right hemicolectomy are lower than those of left hemicolectomy, suggesting that right hemicolectomy is a risk factor for a poor prognosis in patients with T4-stage disease[7].
In addition to the above factors and risk factors such as enterostomy, irregular follow-up, and CA199 level, factors such as advanced age, histopathological type, and lymph node metastasis are also risk factors for colon cancer. Older patients with colorectal cancer have relatively weaker physical function and poorer health status, are often accompanied by other cardiovascular and metabolic diseases, such as diabetes, and have more complications. Tumours in older patients are more likely to be invasive than those in young patients, which may lead to postoperative recurrence and increase the risk of a poor prognosis. Studies have shown that mucinous adenocarcinoma and signet ring cell carcinoma have more aggressive biological behaviour and a worse prognosis than other histological types[8,9]. Patients with colorectal cancer with lymph node metastasis may have residual tumour tissue due to insufficient lymph node dissection or incomplete tumour resection, leading to recurrence[10].
This study has several limitations. First, the number of participants was relatively small, and the data were analysed from a single centre, which may cause bias. Second, the conclusions in the article are all based on retrospective analysis of clinical data from a single centre and lack external validation. Further multi-center studies should be conducted in the future. At the same time, a receiver operating characteristic curve could be added to further verify its accuracy.
1. | Liu B, Zhang ZX, Nie XY, Sun WL, Yan YJ, Fu WH. Clinical outcome and prognostic factors of T4N0M0 colon cancer after R0 resection: A retrospective study. World J Gastrointest Oncol. 2024;16:1869-1877. [PubMed] [DOI] [Cited in This Article: ] [Reference Citation Analysis (5)] |
2. | Govindarajan A, Coburn NG, Kiss A, Rabeneck L, Smith AJ, Law CH. Population-based assessment of the surgical management of locally advanced colorectal cancer. J Natl Cancer Inst. 2006;98:1474-1481. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 3.2] [Reference Citation Analysis (0)] |
3. | Lehnert T, Methner M, Pollok A, Schaible A, Hinz U, Herfarth C. Multivisceral resection for locally advanced primary colon and rectal cancer: an analysis of prognostic factors in 201 patients. Ann Surg. 2002;235:217-225. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 205] [Cited by in F6Publishing: 188] [Article Influence: 8.2] [Reference Citation Analysis (0)] |
4. | Herrera M, Berral-González A, López-Cade I, Galindo-Pumariño C, Bueno-Fortes S, Martín-Merino M, Carrato A, Ocaña A, De La Pinta C, López-Alfonso A, Peña C, García-Barberán V, De Las Rivas J. Cancer-associated fibroblast-derived gene signatures determine prognosis in colon cancer patients. Mol Cancer. 2021;20:73. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 10] [Cited by in F6Publishing: 56] [Article Influence: 14.0] [Reference Citation Analysis (0)] |
5. | Price TJ, Beeke C, Ullah S, Padbury R, Maddern G, Roder D, Townsend AR, Moore J, Roy A, Tomita Y, Karapetis C. Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease? Cancer. 2015;121:830-835. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 94] [Cited by in F6Publishing: 113] [Article Influence: 10.3] [Reference Citation Analysis (0)] |
6. | Benedix F, Kube R, Meyer F, Schmidt U, Gastinger I, Lippert H; Colon/Rectum Carcinomas (Primary Tumor) Study Group. Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival. Dis Colon Rectum. 2010;53:57-64. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 480] [Cited by in F6Publishing: 532] [Article Influence: 35.5] [Reference Citation Analysis (0)] |
7. | Suttie SA, Shaikh I, Mullen R, Amin AI, Daniel T, Yalamarthi S. Outcome of right- and left-sided colonic and rectal cancer following surgical resection. Colorectal Dis. 2011;13:884-889. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 64] [Cited by in F6Publishing: 72] [Article Influence: 5.1] [Reference Citation Analysis (0)] |
8. | Mehrkhani F, Nasiri S, Donboli K, Meysamie A, Hedayat A. Prognostic factors in survival of colorectal cancer patients after surgery. Colorectal Dis. 2009;11:157-161. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 59] [Cited by in F6Publishing: 70] [Article Influence: 4.4] [Reference Citation Analysis (0)] |
9. | Priolli DG, Cardinalli IA, Pereira JA, Alfredo CH, Margarido NF, Martinez CA. Metastatic lymph node ratio as an independent prognostic variable in colorectal cancer: study of 113 patients. Tech Coloproctol. 2009;13:113-121. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis (0)] |
10. | Lupinacci RM, Mello ES, Coelho FF, Kruger JA, Perini MV, Pinheiro RS, Fonseca GM, Cecconello I, Herman P. Prognostic implication of mucinous histology in resected colorectal cancer liver metastases. Surgery. 2014;155:1062-1068. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 19] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis (0)] |